- Issuer ticker
-
ELVN
- Reported as of
-
30 Oct 2026
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
03 Nov 2026, 17:21:24 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Ben Hohl, by power of attorney
Filing notes and source
Key filing fact
Lori Anne Kunkel filed Form 4 for Enliven Therapeutics, Inc. (ELVN) on 03 Nov 2026.
Key facts
- This page summarizes Lori Anne Kunkel's Form 4 filing for Enliven Therapeutics, Inc. (ELVN).
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 03 Nov 2026, 17:21.
Change
- Previous filing in this sequence was filed on 08 Jul 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001536368
Primary reporting owner
Kunkel Lori Anne
- Relationship
-
Director
- Address
- C/O ENLIVEN THERAPEUTICS, INC., 205 PARK ROAD, BURLINGAME
- Signature
- /s/ Ben Hohl, by power of attorney
- Signature date
- 03 Nov 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ELVN
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +3,741
- Change %
- +8.9%
- Price
-
$1.12*
- Shares after
- 45,625
- Date
- 30 Oct 2026
- Ownership
- Direct
ELVN
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +7,300
- Change %
- +16%
- Price
-
$18.30*
- Shares after
- 52,925
- Date
- 30 Oct 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ELVN
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- Shares
- -3,741
- Change %
- -100%
- Price
-
$0.000000*
- Shares after
- 0
- Date
- 30 Oct 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,741
- Exercise price
- $1.12
- Footnotes
- F1
ELVN
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- Shares
- -7,300
- Change %
- -19%
- Price
-
$0.000000*
- Shares after
- 30,582
- Date
- 30 Oct 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,300
- Exercise price
- $18.30
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Explanation of responses
2 footnotes